![]() Pulmonx Pulmonx is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema. | ||
Founding Date | Founding Date 1998 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Redwood City, US HQ Neuchâtel, CH | Locations San Jose, US HQ Nashville, US |
Employees | Employees 2209% increase | Employees 2435% decrease |
Valuation ($) | Valuation ($) 265.1 m | Valuation ($) 53.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $90.5m (FY, 2025) | Revenue (est.) $37.2m (FY, 2022) |
Cost of goods | Cost of goods $23.4m (FY, 2025) | Cost of goods $23m (FY, 2022) |
Gross profit | Gross profit $67.1m (FY, 2025) | Gross profit $14.3m (FY, 2022) |
Net income | Net income ($54m) (FY, 2025) | Net income ($157.5m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 257.4m | Total funding raised $ 206.6m |